Our mission is to make a difference locally in the fight against breast cancer through support, education and research. To accomplish this mission, CT BHI plans on funding a diversified portfolio of clinical/ translational research with emphasis on programs that have not yet qualified for federal grants targeting breast cancer cause and survival.
Through the support of our signature fundraiser, the CT RACE IN THE PARK, the Annual Howard Belkin Memorial Golf Tournament, other events, individual donations and corporate support, the CT BHI will contribute monies this year to programs that aim to fulfill our mission. This funding is limited and awarded through a competitive process. All grant applications are subjected to rigorous review by a GRANTS PANEL of medical professionals, breast cancer survivors, educators, public health and interested business professionals that is responsible for making recommendations to the CT BHI Board of Directors. The funding period is for 12 months to be awarded in October, breast cancer awareness month.
New Dates for Submission
HOW TO APPLY FOR A 2017 GRANT FROM THE CT BREAST HEALTH INITIATIVE:
Applying is a two-step process:
- All applicants are asked to submit a letter of intent (executive summary) of no more than two pages by March 1, 2017.
- If you are invited to submit a full grant application, it must be submitted by May 1, 2017.
If you have any questions regarding the CT Breast Health Initiative, Inc. grants, please contact 860.827.7103 or email email@example.com.
Research and Educational Grants
To date, CT BHI has awarded $3.4 million in Connecticut research grants.
2015 Community Education Grant
The Hispanic Center of Greater Danbury, Inc.
Andrea Contreras-Munoz - The Hispanic Center Breast Cancer Program
MidState Medical Center
Denise Jones-Gagne - Integrative Therapies for Breast Health
Witness Project of Connecticut, Inc.
Marilyn Moore - Educate and Empower Through Patient Navigation
2015 Clinical Research Grants
Western Connecticut Health Network
John Martignetti, M.D., Ph.D.
Personalized Genomic Medicine Leads Beyond BRCA to Predict a Women’s Risk of Breast Cancer: Identification of Novel Breast Cancer Genes in Women Who are BRCA-negative
University of Connecticut Health Center
Henry Smilowitz, Ph.D.
Disparities in Breast Cancer: Is elevated serum sLAG-3 a pre-dictor of more aggressive disease in African-American Women
Xiaoyan Wang, Ph.D.
Identifying Underdiagnosed and Undertreated Cancer-Related Fatigue in Breast Cancer Survivors
For information on our Grants Policy, please refer to the following documents: